Taking the medication mavacamten for HCM can reduce obstruction in your heart. Learn about its benefits, risks, and side ...

The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the ...

A multicentre study shows AI-enabled ECG screening can be integrated into clinical workflows to detect previously undiagnosed hypertrophic cardiomyopathy and accelerate follow-up.

Learn about sudden cardiac death risk in people with hypertrophic cardiomyopathy, including risk factors, prevention methods, ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Together, we’ll explore safe fitness options and practical guidance to help individuals with HCM stay physically active while ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A small panel of ...

with the Disease, Inspired by the Experience with HCM of ...

Women with prior GH or PE are at greater risk of common initial manifestations of CVD. A new study reported heterogenous associations across a range of acute and chronic cardiovascular diseases in ...